HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation

Bone Marrow Transplant. 2021 Jul;56(7):1723-1727. doi: 10.1038/s41409-021-01231-y. Epub 2021 Mar 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Graft vs Host Disease*
  • HLA Antigens
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility Antigens Class II
  • Histocompatibility Testing
  • Humans

Substances

  • HLA Antigens
  • Histocompatibility Antigens Class II